Literature DB >> 7662494

Clinical application of 62Zn/62Cu positron generator: perfusion and plasma pool images in normal subjects.

H Okazawa1, Y Fujibayashi, Y Yonekura, N Tamaki, S Nishizawa, Y Magata, K Ishizu, T Tsuchida, N Sadato, J Konishi.   

Abstract

We have developed a new 62Zn/62Cu positron generator, and applied it for PET imaging of perfusion and plasma volume in 5 normal subjects. The generator makes it possible by a simple procedure to obtain 62Cu eluate and labeling compounds sufficiently every 40-60 minutes. 62Cu labeled pyruvaldehyde bis(N4-methylthiosemicarbazone) copper II (62Cu-PTSM) was employed for cerebral and myocardial perfusion imaging and 62Cu labeled human serum albumin-dithiosemicarbazone (62Cu-HSA-DTS) was used for plasma pool imaging. The images of cerebral blood flow, cerebral plasma volume and myocardial perfusion were excellent. In addition, the analysis of tissue activity and blood activity demonstrated the microspheric character of 62Cu-PTSM. Correction of arterial activity with the standard disappearance curve of 62Cu-PTSM suggested the possibility of quantifying blood flow. The results of this study indicate the capability of the 62Zn/62Cu generator for wide clinical use without an in-house cyclotron.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7662494     DOI: 10.1007/bf03164971

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  20 in total

1.  62Cu-labeling of human serum albumin-dithiosemicarbazone (HSA-DTS) conjugate for regional plasma volume measurement: application of new 62Zn/62Cu generator system.

Authors:  Y Fujibayashi; K Matsumoto; Y Arano; Y Yonekura; J Konishi; A Yokoyama
Journal:  Chem Pharm Bull (Tokyo)       Date:  1990-07       Impact factor: 1.645

2.  THE ANTI-TUMOR ACTIVITY OF 2-KETO-3-ETHOXYBUTYRALDEHYDE BIS(THIOSEMICARBAZONE) AND RELATED COMPOUNDS.

Authors:  H G PETERING; H H BUSKIRK; G E UNDERWOOD
Journal:  Cancer Res       Date:  1964-04       Impact factor: 12.701

3.  Copper-62-labeled pyruvaldehyde bis(N4-methylthiosemicarbazonato)copper(II): synthesis and evaluation as a positron emission tomography tracer for cerebral and myocardial perfusion.

Authors:  M A Green; C J Mathias; M J Welch; A H McGuire; D Perry; F Fernandez-Rubio; J S Perlmutter; M E Raichle; S R Bergmann
Journal:  J Nucl Med       Date:  1990-12       Impact factor: 10.057

4.  Evaluation of a potential generator-produced PET tracer for cerebral perfusion imaging: single-pass cerebral extraction measurements and imaging with radiolabeled Cu-PTSM.

Authors:  C J Mathias; M J Welch; M E Raichle; M A Mintun; L L Lich; A H McGuire; K R Zinn; E K John; M A Green
Journal:  J Nucl Med       Date:  1990-03       Impact factor: 10.057

5.  Assessment of regional myocardial and renal blood flow with copper-PTSM and positron emission tomography.

Authors:  M E Shelton; M A Green; C J Mathias; M J Welch; S R Bergmann
Journal:  Circulation       Date:  1990-09       Impact factor: 29.690

6.  The zinc-62/copper-62 generator: a convenient source of copper-62 for radiopharmaceuticals.

Authors:  G D Robinson; F W Zielinski; A W Lee
Journal:  Int J Appl Radiat Isot       Date:  1980-02

7.  Development of a high performance zinc-62/copper-62 radionuclide generator for positron emission tomography.

Authors:  J Zweit; R Goodall; M Cox; J W Babich; G A Potter; H L Sharma; R J Ott
Journal:  Eur J Nucl Med       Date:  1992

8.  A new zinc-62/copper-62 generator as a copper-62 source for PET radiopharmaceuticals.

Authors:  Y Fujibayashi; K Matsumoto; Y Yonekura; J Konishi; A Yokoyama
Journal:  J Nucl Med       Date:  1989-11       Impact factor: 10.057

9.  Copper(II) bis(thiosemicarbazone) complexes as potential tracers for evaluation of cerebral and myocardial blood flow with PET.

Authors:  M A Green; D L Klippenstein; J R Tennison
Journal:  J Nucl Med       Date:  1988-09       Impact factor: 10.057

10.  [Noninvasive and simple method for the estimation of myocardial metabolic rate of glucose by PET and 18F-FDG].

Authors:  N Takahashi; N Tamaki; M Kawamoto; Y Magata; K Okuda; R Nohara; S Sasayama; Y Yonekura; J Konishi; K Yamamoto
Journal:  Kaku Igaku       Date:  1994-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.